{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:55:16Z","timestamp":1794002116506,"version":"4.8.0"},"reference-count":37,"publisher":"Informa UK Limited","issue":"21","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"name":"Daiichi Sankyo","award":["NCT06899126"],"award-info":[{"award-number":["NCT06899126"]}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2026,9,2]]},"DOI":"10.1080\/14796694.2026.2724696","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T07:25:51Z","timestamp":1788333951000},"page":"2559-2567","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["DESTINY-Lung06: trastuzumab deruxtecan and pembrolizumab as first-line treatment for HER2-overexpressing, PD-L1 TPS\u2009&lt;50% NSCLC"],"prefix":"10.1080","volume":"22","author":[{"given":"Pasi A.","family":"J\u00e4nne","sequence":"first","affiliation":[{"name":"Dana-Farber Cancer Institute","place":["Boston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cai-Cun","family":"Zhou","sequence":"additional","affiliation":[{"name":"Shanghai East Hospital Affiliated to Tongji University","place":["Shanghai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert F.","family":"Smit","sequence":"additional","affiliation":[{"name":"Leiden University Medical Center","place":["Leiden, The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enriqueta","family":"Felip","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron University Hospital & Vall d\u2019Hebron Institute of Oncology (VHIO)","place":["Barcelona, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"George","family":"Blumenschein","sequence":"additional","affiliation":[{"name":"The University of Texas MD Anderson Cancer Center","place":["Houston, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Goto","sequence":"additional","affiliation":[{"name":"National Cancer Center Hospital East","place":["Kashiwa, Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William N.","family":"William","sequence":"additional","affiliation":[{"name":"Grupo Oncocl\u00ednicas","place":["S\u00e3o Paulo, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chihiro","family":"Abe","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lin","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yen","family":"Cheng","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaline","family":"Pereira","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc","place":["Basking Ridge, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"key":"e_1_3_8_3_1","unstructured":"American Cancer Society Inc. Cancer facts & figures 2023. [cited 2026 Jun 4]. Available from: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2023\/2023-cancer-facts-and-figures.pdf"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21871"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101371"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/852748"},{"key":"e_1_3_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.10.025"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-015-9552-6"},{"key":"e_1_3_8_10_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.4836"},{"key":"e_1_3_8_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2025.1791"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.77.8738"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3798106"},{"key":"e_1_3_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.08.005"},{"issue":"14","key":"e_1_3_8_15_1","first-page":"5238","article-title":"HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin","volume":"9","author":"Heinm\u00f6ller P","year":"2003","unstructured":"Heinm\u00f6ller P, Gross C, Beyser K, et al. HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin. Clin Cancer Res. 2003;9(14):5238\u20135243.","journal-title":"Clin Cancer Res"},{"key":"e_1_3_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2003.09.026"},{"issue":"12","key":"e_1_3_8_17_1","first-page":"4631","article-title":"The prognostic significance of HER2 overexpression in non-small cell lung cancer","volume":"31","author":"Takenaka M","year":"2011","unstructured":"Takenaka M, Hanagiri T, Shinohara S, et al. The prognostic significance of HER2 overexpression in non-small cell lung cancer. Anticancer Res. 2011;31(12):4631\u20134636.","journal-title":"Anticancer Res"},{"key":"e_1_3_8_18_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171280"},{"key":"e_1_3_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181f26266"},{"key":"e_1_3_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2021.100260"},{"key":"e_1_3_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100395"},{"key":"e_1_3_8_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-025-01016-y"},{"key":"e_1_3_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.12.009"},{"key":"e_1_3_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.12.013"},{"key":"e_1_3_8_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdy554"},{"key":"e_1_3_8_26_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01989"},{"key":"e_1_3_8_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41379-019-0339-0"},{"key":"e_1_3_8_28_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw378.14"},{"key":"e_1_3_8_29_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801005"},{"key":"e_1_3_8_30_1","unstructured":"ENHERTU\u00ae. (Fam-trastuzumab deruxtecan-nxki) for injection for intravenous use. Prescribing information. Basking Ridge (NJ): Daiichi Sankyo Inc.; 2026 [updated May 2026; cited 2026 Aug 17]. Available from: https:\/\/daiichisankyo.us\/prescribing-information-portlet\/getPIContent?productName=Enhertu&inline=true"},{"key":"e_1_3_8_31_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02005"},{"key":"e_1_3_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00064-0"},{"key":"e_1_3_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00380-2"},{"key":"e_1_3_8_34_1","unstructured":"Planchard D Kim HR Suksombooncharoen T et al. Trastuzumab deruxtecan monotherapy in pretreated HER2-overexpressing nonsquamous non-small cell lung cancer: DESTINY-Lung03 part 1. [cited 2026 Mar 19]. Available from: https:\/\/datasourcebydaiichisankyo.com\/documents\/20833\/21632\/WCLC_TDXd_Planchard_Oral_Final.pdf"},{"key":"e_1_3_8_35_1","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-17-0749"},{"key":"e_1_3_8_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.iotech.2024.100747"},{"key":"e_1_3_8_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.09.2354"},{"key":"e_1_3_8_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2024.08.2347"},{"key":"e_1_3_8_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2021.04.008"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2724696","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14796694.2026.2724696","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2724696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:10:05Z","timestamp":1793689805000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2026.2724696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":37,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026,9,2]]}},"alternative-id":["10.1080\/14796694.2026.2724696"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2026.2724696","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}